Cathie Wood has won investors’ confidence with her funds’ significant gains last year. The renowned investor believes that investing in innovation is the key to success. And Wall Street analysts are bullish on Zillow (Z) and Fate Therapeutics (NASDAQ:FATE), which are held in Wood’s Ark Innovation ETF portfolio. Read on.ARK investment services founder Cathie Wood is one of the most popular institutional investors. Wood gained popularity after her strategic investments generated big gains last year. Her Ark Innovation ETF (ARKK) is focused on the long-term growth of capital, investing at least 65% of its assets in domestic and foreign equity securities.
Wood expects these companies have the potential for ‘disruptive innovation.’ The ETF has gained 86.4% over the past year.
ARKK holds a substantial stake in Zillow Group (NASDAQ:ZG), Inc. (Z) and Fate Therapeutics, Inc. (FATE). As of September 9, ARKK held 6,470,458 shares of Z, representing 2.8% of ARKK’s portfolio, while FATE represented nearly 2% of the portfolio. These two stocks are among ARKK’s top 20 holdings. And, given their sound fundamentals and disruptive growth prospects, Wall Street analysts expect them to rally by 40% in price soon.